ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mario Chiavarelli
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiavarelli, M.
Right arrow Articles by del Basso, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiavarelli, M.
Right arrow Articles by del Basso, P.

Ann Thorac Surg 1992;53:455-459
© 1992 The Society of Thoracic Surgeons


Articles

Effects of cardioplegic solutions and their components on human saphenous vein contractility

Mario Chiavarelli, MD, PhD*, Fulvia Fabi, MD, Tonino Stati, MD, Roberto Chiavarelli, MD, Paola del Basso, MSc

Department of Cardiovascular Surgery, University of Rome "La Sapienza", and Department of Pharmacology, Istituto Superiore di Sanita, Rome, Italy

Accepted for publication August 27, 1991.

* Address reprint requests to Dr Chiavarelli, Division of Cardiothoracic Surgery, Loma Linda University Medical Center, 11234 Anderson St, Loma Linda, CA 92354 USA.

Cardioplegic solution administration into the vein graft is an established method to ensure cardioplegic distribution beyond coronary artery stenoses. The ultrastructural demonstration of severe endothelial damage after cardioplegic exposure suggests that intravenous cardioplegic administration can contribute to early and late graft thrombosis. The direct effect on human saphenous vein contractility of three cardioplegic solutions and their components was compared. A solution with 30 mmol/L K+ and 82 mmol/L Na+ produced intense venoconstriction. Lowering the potassium level to 10 mmol/L and increasing the sodium level to 92 mmol/L reduced its vasoconstricting action. A third solution with 16 mmol/L K+, 16 mmol/L Mg2+, and lidocaine caused venodilatation. Analysis of the single component effects showed that high potassium level, low sodium level, and the addition of lidocaine produced concentration-dependent vasoconstriction. High magnesium concentration resulted in vasodilatation. The present data suggest that cardioplegic solution composition may cause marked vasomotor effects on saphenous vein and thus influence its endothelial integrity. In the search for an "ideal solution" to the cardioplegic controversy, a venoconstrictor infusate should be avoided to improve patency rates of coronary artery bypass grafts.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. Menasche
Blood Cardioplegia: Do We Still Need to Dilute?
Ann. Thorac. Surg., October 1, 1996; 62(4): 957 - 960.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. M. Sanchez, T. A. Wooldridge, L. E. Boerboom, G. N. Olinger, G. H. Almassi, and N. J. Rusch
Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution
J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1445 - 1453.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.